SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies shines on getting GMP certification for antibiotic-carbapenem facility

31 Dec 2024 Evaluate

Venus Remedies is currently trading at Rs. 325.85, up by 15.40 points or 4.96% from its previous closing of Rs. 310.45 on the BSE.

The scrip opened at Rs. 300.00 and has touched a high and low of Rs. 327.85 and Rs. 300.00 respectively. So far 1933 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 429.60 on 05-Jan-2024 and a 52 week low of Rs. 280.00 on 13-Mar-2024.

Last one week high and low of the scrip stood at Rs. 327.85 and Rs. 300.00 respectively. The current market cap of the company is Rs. 438.24 crore.

The promoters holding in the company stood at 41.76%, while Institutions and Non-Institutions held 1.18% and 57.06% respectively.

Venus Remedies has received Good Manufacturing Practice (GMP) certification from Ministry of Health of Moldova for its antibiotic-carbapenem facility. With this certification, it is now well-positioned to further extend its presence in the Eastern European market, ensuring access to high-quality, effective, and reliable antibiotics for healthcare providers and patients across the region.   

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.


Venus Remedies Share Price

1559.15 74.20 (5.00%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.35
Dr. Reddys Lab 1267.05
Cipla 1397.75
Zydus Lifesciences 1085.45
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×